Panzyga 100 mg/ml Infusionslösung, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung clinical trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infections in Patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment with B-cell Depletion Therapy ("PROTECT")

This study looks at a medicine called Panzyga to see if it can prevent serious infections in people with certain autoimmune conditions. Participants receive either Panzyga or a salt solution to see if the medicine helps keep them healthier.